Overview
- University of Eastern Finland researchers report that lithium chloride lowered Tau phosphorylation at known sites and revealed new Alzheimer’s-relevant sites in two cell models.
- Proteomic analyses indicate effects on the Tau kinase GSK-3β and predict shifts in several other kinases, pointing to broader enzyme networks influenced by lithium.
- The study also found changes in Rho GTPase signaling, a switch system that shapes the cell’s internal scaffolding and movement.
- The team highlights evidence that amyloid-beta plaques can trap inorganic lithium salts, prompting tests of organic forms that might remain available to cells.
- Because the work is preclinical and one model used high doses, the authors call for animal studies, dose-ranging tests, and trials that compare lithium formulations.